AstraZeneca News Monitoring

BMJ finds inaccuracies in key studies for AstraZeneca’s blockbuster heart drug ticagrelor

In a follow up investigation into the multibillion dollar drug ticagrelor, The BMJ has uncovered fresh concerns, this time in key platelet studies used in its FDA approval.  For more than a decade, ticagrelor (Brilinta in the US and Brilique in Europe) has …

Top medics issue urgent warning over heart drug taken by millions - as makers AstraZeneca are accused of 'misreporting' ...

Millions of patients at high risk of a fatal heart attack could be taking a drug that may not even be effective, top doctors have warned.  Anti-clotting pill ticagrelor was approved for use on the NHS in 2011 after trials claimed it could prevent one in …

Ticagrelor doubts: inaccuracies uncovered in key studies for AstraZeneca’s billion dollar drug

What we found The multibillion dollar heart drug ticagrelor (Brilinta, Brilique) goes generic this year. Last December, a BMJ investigation found serious data integrity problems in the landmark 18 000 patient PLATO study,1 calling into question the drug’s …

BlackDoctor Foundation & AstraZeneca Present: “Community Voices Against Cancer & Lupus”

On Monday, June 23, 2025, the BlackDoctor Foundation, in partnership with AstraZeneca’s Accelerate Change Together (ACT) initiative, will present a groundbreaking panel: Community Voices Against Cancer & Lupus. This powerful event is part of the first- …

AstraZeneca’s Ultomiris shows promise in rare post-transplant complication

AstraZeneca (AZ) has announced promising results from a late-stage study of its C5 complement inhibitor Ultomiris (ravulizumab) in paediatric patients with a life-threatening post-transplant complication. The phase 3 ALXN1210-TMA-314 trial has been …

FTSE 100 Live: Stocks drop into the red, AstraZeneca and GSK fall...

FTSE 100 falls 8 points to 8,826 UK inflation remains at 3.4% in May, well above BoE target ONS wrongly reports that annual inflation fell, when it was flat Israel-Iran tensions remain, but oil prices flatten off   12.05pm: FTSE and US futures drop The …

AstraZeneca inks collaboration worth $3.6 B with CSPC Pharma focused on AI-enabled research in China

AstraZeneca inks collaboration worth $3.6 B with CSPC Pharma focused on AI-enabled research in China June 18, 2025 | Wednesday | News To treat diseases across chronic indications, including a pre-clinical small molecule oral therapy for immunological …

AI Framework from University of Sheffield and AstraZeneca Enhances Protein Design for Drug Development

A new AI-driven approach developed by researchers at the University of Sheffield, AstraZeneca, and the University of Southampton could make it easier to design proteins crucial for emerging therapies. Image Credit: Anggalih Prasetya/Shutterstock.com …

Astrazeneca makes $5.3B drug R&D pact with CSPC

CSPC Pharmaceutical Group Ltd. announced June 13 that it struck a potential $5.33 billion deal with Astrazeneca plc to develop novel preclinical small-molecule candidates using CSPC’s AI-driven drug development platform. BioWorld Cancer Cardiovascular …

AstraZeneca touts early Ultomiris survival data in children living with rare post-transplant complication

Now that Ultomiris has matched the indications of its predecessor Soliris, AstraZeneca is eyeing new avenues for the C5 drug to make its mark. Next up, the complement inhibitor—which AZ inherited in its $39 billion Alexion purchase—could help address a …

British-Swedish AstraZeneca has entered into a strategic partnership with China's CSPC Pharmaceuticals

AK&M 16 June 2025 17:45 AstraZeneca plc, a British-Swedish multinational pharmaceutical and biotechnology company, has entered into a strategic partnership agreement with China's CSPC Pharmaceuticals Group Limited to develop new oral drugs based on …

CSPC and Astrazeneca establish strategic research collaboration

Immune CSPC Pharmaceutical Group Ltd. has entered into a strategic research collaboration agreement with Astrazeneca plc for the discovery and development of novel oral small-molecule candidates utilizing the group’s AI-driven, dual-engine efficient drug …

EHA 2025: AstraZeneca’s surovatamig is potential next-gen BiTE for R/R B-ALL

At the 2025 Congress of the European Hematology Association (EHA 2025), held from 12 June 12 to 15 June in Milan, Italy, preliminary dose-escalation and optimisation results from the global, multicentre, open-label, single-arm Phase I/II SYRUS clinical …

AstraZeneca and CSPC Pharmaceuticals enter AI-driven partnership worth $5.3bn

AstraZeneca (AZ) and CSPC Pharmaceuticals Group have entered into a partnership worth up to $5.3bn to develop therapies for chronic conditions. The strategic research collaboration will focus on the discovery and development of pre-clinical oral candidates …

AstraZeneca signs $5.2bn deal to develop drugs for chronic disease with Chinese biotech

AstraZeneca in deal with China firm worth up to £4bn

By CITY & FINANCE REPORTER Updated: 16:50 EDT, 13 June 2025 AstraZeneca has agreed a deal that could be worth almost £4billion with a Chinese company to use AI in the production of new treatments for chronic diseases. Britain's largest listed …

AstraZeneca signs $5.2bn deal to develop drugs for chronic disease with Chinese biotech

Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. AstraZeneca has signed a deal worth up to $5.2bn to work with a Chinese biotech company using AI to develop new treatments for …

AstraZeneca inks China AI research deal for chronic diseases

British drugmaker AstraZeneca unveiled on Friday an AI-assisted research partnership with Chinese counterpart CSPC Pharmaceuticals worth up to $5.3 billion to tackle chronic diseases. AstraZeneca, which has a pre-existing collaboration with CSPC, announced …

AstraZeneca and CSPC Pharmaceuticals to Partner on AI-Enabled Research

AstraZeneca has announced its entry into a strategic research collaboration with CSPC Pharmaceuticals Group, based in Shijiazhuang City, China, which was made public in a press release on June 13, 2025 (1). The two companies plan to work together to …

Japan Gene Therapy Market Growth: $148.06M in 2024 to $904.94M by 2033 | CAGR 20.3%

Japan's Gene Therapy Market is set to grow from $148.06M in 2024 to $904.94M by 2033, driven by innovation and a strong CAGR of 20.3% during 2025–2033. AUSTIN, TX, UNITED STATES, June 20, 2025 /⁨EINPresswire.com⁩/ -- Japan Gene Therapy …

Dr. Mohana Rao Patibandla Named “The Best Neurosurgeon to Watch in 2025” by Insights Success Magazine

Dr. Mohana Rao Patibandla Named “The Best Neurosurgeon to Watch in 2025” by Insights Success Magazine GUNTUR, ANDHRA PRADESH, INDIA, June 20, 2025 /⁨EINPresswire.com⁩/ -- Dr. Mohana Rao Patibandla Named “The Best Neurosurgeon to Watch in 2025” by …

ImagineHealth Partners with Deep Longevity to Bring Biological Age Testing to Thai Providers

BANGKOK, BANGKOK, THAILAND, June 20, 2025 /⁨EINPresswire.com⁩/ -- ImagineHealth, Thailand’s leading Longevity Facilitator, is proud to announce its exclusive partnership with Deep Longevity, a global leader in AI-powered aging clocks and biological …

LATAM Women's HSDD Treatment Market Sees Steady Growth to $170 Million (3.8% CAGR)

Hyposexual desire disorder (HSDD) in women is defined as deficiency or lack of sexual fantasies and desire of sexual activity. PORTLAND, OR, UNITED STATES, June 20, 2025 /⁨EINPresswire.com⁩/ -- Allied Market Research recently said "LATAM …

Antifibrinolytic Drugs Market: Major Growth & Business Opportunities with Akorn, Bayer, Mylan, Pfizer

Antifibrinolytic drugs are used to prevent fibrinolysis or lysis of blood clots or thrombus. PORTLAND, OR, UNITED STATES, June 20, 2025 /⁨EINPresswire.com⁩/ -- The Antifibrinolytic Drugs Market size was estimated at $13.59 billion in 2018 and is …

10.0% CAGR Fuels Top 10 Cancer Drugs Market to $198.8 Billion by 2032

The top 10 cancer drugs market size is estimated to reach $198.8 billion by 2032, exhibiting a CAGR of 10.0% from 2023 to 2032. PORTLAND, OR, UNITED STATES, June 20, 2025 /⁨EINPresswire.com⁩/ -- Allied Market Research published a report, titled, …

Global Cough Remedies Market to Expand Rapidly as Cold and Flu Cases Rise | Projected to Reach $9.91 Billion by 2030

The global Cough Remedies market size was valued at $7084.5 million in 2020, and is projected to reach $9911.2 million by 2030, registering a CAGR of 3.4%. PORTLAND, OR, UNITED STATES, June 20, 2025 /⁨EINPresswire.com⁩/ -- According to the report …

The Artificial Intelligence in Medicines Market Is Set to Reach $18,119 Million | CAGR of 49.6%

The global artificial intelligence in medicines market was valued at $719 million in 2022 and is estimated to reach $18,119 million at a CAGR of 49.6%. PORTLAND, OR, UNITED STATES, June 20, 2025 /⁨EINPresswire.com⁩/ -- The global Artificial …

Parkinson's disease Drug Market | Forecasted to Cross Valuation of $10.4 Billion by 2031

The global Parkinson's disease drugs market size is projected to reach $10.4 billion by 2031, growing at a CAGR of 6.2% from 2022 to 2031. PORTLAND, OR, UNITED STATES, June 20, 2025 /⁨EINPresswire.com⁩/ -- Parkinson's disease (PD) drug …

Productive Dentist Academy Announces First Clinical Calibration™ Institute Mastermind

New Program Tackles Inconsistent Patient Care & Low Case Acceptance with Team-based Training, Now for $595/Month with Founders Promo ANACORTES, WA, UNITED STATES, June 19, 2025 /⁨EINPresswire.com⁩/ -- A lack of alignment among doctors and …

Immune Cell Therapy Market Set to Witness Significant Growth by 2025-2032 | Novartis, Autolus, Bluebird Bio, Cellectis

BURLINGAME, CA, UNITED STATES, June 19, 2025 /⁨EINPresswire.com⁩/ -- The latest research study released by Coherent Market Insights on "Immune Cell Therapy Market 2025 Forecast to 2032" research provides accurate economic, global, and …

Slidell Dental Clinic Outlines Key Differences Between Bonding, Veneers, and Crowns for Cosmetic and Restorative Care

SLIDELL, LA, UNITED STATES, June 19, 2025 /⁨EINPresswire.com⁩/ -- As cosmetic dentistry becomes increasingly common among adults seeking both improved function and aesthetics, understanding the distinct purposes of bonding, veneers, and crowns …

Cybersecurity Services Now Available for Small Businesses in Gilbert, Arizona

AZCOMP Technologies expands cybersecurity offerings in Gilbert to help small businesses protect against evolving digital threats. MESA, AZ, UNITED STATES, June 19, 2025 /⁨EINPresswire.com⁩/ -- AZCOMP Technologies, a leading IT services provider based in …

Wellbridge Addiction Treatment and Research Eases the Transition Into Treatment with Compassionate Admissions Process

NEW YORK, NY, UNITED STATES, June 19, 2025 /⁨EINPresswire.com⁩/ -- Entering addiction treatment for the first time can be a daunting and emotional experience. Wellbridge NYC Drug & Alcohol Rehab, a premier provider of evidence-based addiction …

The Future of Medicine Arrives: Gene Matrix Launches Revolutionary AI-Powered Cancer and PGx Tests in Slovenia

Chicago-based AI-genomics leader introduces its pioneering GeneCancer™ and GenePGx™ tests to the European market, starting with a strategic launch in Slovenia. CHICAGO, IL, UNITED STATES, June 19, 2025 /⁨EINPresswire.com⁩/ -- In a landmark move …

Australia Pathology Lab Services Market 2025: Size, Share, Report | 2033

Australia pathology lab services market size reached USD 10,763.64 Million 2024, is expected USD 24,865.65 Million 2033, growing at a CAGR of 9.75% 2025-2033. LAZIO, UNITED STATES, June 19, 2025 /⁨EINPresswire.com⁩/ -- The latest report by IMARC …

New Wave in gMG Care: Cutting‑Edge Biologics Transform Treatment Landscape | Competitive Intelligence

Biologics revolutionize generalized myasthenia gravis care with fast-acting, patient-friendly therapies and a robust global pipeline redefining outcomes. AUSTIN, TX, UNITED STATES, June 20, 2025 /⁨EINPresswire.com⁩/ -- Generalized Myasthenia …

Clear Skin, Clear Confidence: Dr. Brooke Jeffy Offers Expert Acne Solutions for Teens and Adults in Scottsdale

SCOTTSDALE, AZ, UNITED STATES, June 19, 2025 /⁨EINPresswire.com⁩/ -- Acne is one of the most common skin concerns affecting both teenagers and adults alike. From hormonal fluctuations to lifestyle and nutritional triggers, acne is a multifaceted …

VisionMed Appoints Dr. Frantz Lerebours as Medical Advisor for AI-Powered Surgical Video Analysis Platform

Orthopedic surgeon and Miami Heat team physician joins VisionMed to guide clinical use of AI-powered surgical video analysis platform EMMA™ MIAMI, FL, UNITED STATES, June 19, 2025 /⁨EINPresswire.com⁩/ -- VisionMed, an AI healthcare innovator …

Seeing Beyond Sight: New Frontiers in AMD Treatment-Gene Therapy and Biosimilars Take Center Stage | CI Intelligence

Pioneering AMD therapies-gene therapy, biosimilars, long‑acting biologics-promise durable vision gains and reduced injection burden for aging populations. AUSTIN, TX, UNITED STATES, June 19, 2025 /⁨EINPresswire.com⁩/ -- Revolutionizing AMD Care: …